Breakthroughs in Small Animal Imaging_Technical Insights

Breakthroughs in Small Animal Imaging_Technical Insights

The Future to Disease Detection and Prevention

RELEASE DATE
29-Jun-2015
REGION
North America
Research Code: D690-01-00-00-00
SKU: HC02421-NA-TR_16543
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02421-NA-TR_16543

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The small animal imaging or in vivo preclinical imaging market began to come into existence from the early 1990s when scientists studying biology and disease processes realized that clinical image could help them reduce the cost of research and time span of their animal studies. At present, medical imaging is an important tool in research applications focused toward drug discovery/ development and in the understanding of basic pathological physiology, where changes at the cellular or molecular level in animal models must be closely monitored over time. Broadly, the technology can be segmented into optical imaging, micro computed tomography (micro-CT), micro-MRI, nuclear imaging and micro-ultrasonography (micro-USG) imaging modalities. Most common small animal in vivo imaging devices used in pre-clinical applications are optical imaging and nuclear imaging modalities such as micro positron emission tomography (micro-PET) and micro single-photon emission computed tomography (micro-SPECT). Routine application of small animal imaging in bio-distribution and drug development together contributed to almost 70 percent of all application in 2014.

Table of Contents

Research Scope

Research Process Methodology

Research Methodology

Key Findings

Technology Overview

Technology Overview (continued)

Technology Overview (continued)

Technology Overview (continued)

Technology Value Chain

Technology Value Chain (continued)

Technology Capability

Technology Capability (continued)

Market Impact of Key Innovations

Market Impact of Key Innovations

Market Impact of Key Innovations

Market Impact

Market Drivers

Market Challenges

Technology Adoption

Technology Adoption

End-User Requirements

End-User Requirements (continued)

Emerging Trends

Technology Roadmap

Technology Roadmap

Technology Roadmap

Technology Roadmap

Technology Roadmap

Technology Management Strategies

Key Patents

Key Patents (continued)

Key Patents (continued)

Contacts

Legal Disclaimer

Appendix

Appendix

Appendix

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
The small animal imaging or in vivo preclinical imaging market began to come into existence from the early 1990s when scientists studying biology and disease processes realized that clinical image could help them reduce the cost of research and time span of their animal studies. At present, medical imaging is an important tool in research applications focused toward drug discovery/ development and in the understanding of basic pathological physiology, where changes at the cellular or molecular level in animal models must be closely monitored over time. Broadly, the technology can be segmented into optical imaging, micro computed tomography (micro-CT), micro-MRI, nuclear imaging and micro-ultrasonography (micro-USG) imaging modalities. Most common small animal in vivo imaging devices used in pre-clinical applications are optical imaging and nuclear imaging modalities such as micro positron emission tomography (micro-PET) and micro single-photon emission computed tomography (micro-SPECT). Routine application of small animal imaging in bio-distribution and drug development together contributed to almost 70 percent of all application in 2014.
More Information
No Index No
Podcast No
Author Darshana De
Industries Healthcare
WIP Number D690-01-00-00-00
Keyword 1 small animal imaging
Keyword 2 Small Animal Imaging
Keyword 3 in vivo preclinical imaging
Is Prebook No